We are live on
!
Find out more
Kura Oncology
KURA
KURA
220 hedge funds and large institutions have $686M invested in Kura Oncology in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 70 increasing their positions, 82 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 26
3% more funds holding
Funds holding: 214 → 220 (+6)
7% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $2.34M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.56% less ownership
Funds ownership: 98.09% → 95.53% (-2.6%)
15% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 82
23% less capital invested
Capital invested by funds: $888M → $686M (-$202M)
Holders
220
Holders Change
+6
Holders Change %
+2.8%
% of All Funds
2.71%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
36
Increased
70
Reduced
82
Closed
26
Calls
$2.5M
Puts
$2.34M
Net Calls
+$162K
Net Calls Change
-$786K
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$22.7M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$7.11M |
| 3 |
BlackRock
New York
|
+$5.38M |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$3.48M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$3.33M |
